ozempic semaglutide patent expiry The upcoming of the in India in mid-March 2026 is expected to transform the country's diabetes treatment landscape. Ahead of this, industry experts predict that the development will open Semaglutide (Ozempic) Market: Navigating The

Metformin is an oral medication that is gaining some traction, but like Ozempic, it is only FDA-approved to treat type 2 diabetes

Intraoperative molecular imaging: 3rd biennial clinical trials update

Wegovy, semaglutide, a version of GLP-1 at full dosage releases 5 times the blood level of a Thanksgiving feast

Epidermal Renewal Corrections within the deep layer of the epidermis

Relieving the beta cell of these burdens may provide an opportunity to save the beta cell without resorting to aggressive immune suppression

Integrating functional genomics and molecular profiling into future cardiovascular outcome studies could help define responder subgroups and refine precision cardiometabolic strategies